David Glass

Company: Regeneron

Job title: Vice President - Research

Seminars:

Panel Discussion: Navigating Best Practices to Promote Patient Adherence to GLP-1s for Good Quality, Durable Weight Loss 2:00 pm - 2:30 pm

Discussing the value of support in lifestyle choices to support the healthy and productive administration of GLP-1s – should it be compulsory to provide lifestyle management programs along with GLP-1 therapeutics Understanding financial barriers to adherence such as changing insurance landscape for weight loss drugs Highlighting the importance of education and support to ensure that…Read more

day: Day Two

Considerations for Aging Users of GLP-1s Using Sarcopenia as a Case Study 12:00 pm - 12:30 pm

Discussing the potential impact of GLP-1 receptor agonists on sarcopenia in aging populations Exploring the complex interplay between GLP-1 signaling, muscle mass, and function Examining the potential for GLP-1s to contribute to muscle loss or, conversely, to have beneficial effects on muscle mass and function in older adultsRead more

day: Day One